The U.S. Food and Drug Administration has approved a first vaccine to treat prostate cancer. The price tag? $93,000.
Of course, this “vaccine”, Provenge, doesn't actually prevent cancer. It also doesn't cure cancer. So what does it do?
According to USA Today:
“... studies show that the vaccine does help men with advanced prostate cancer live four months longer ... Many men on Provenge developed mild symptoms, such as fevers, chills and headaches. One in four patients had a serious side effect ... with 3.5 percent suffering a stroke ...”